Risk Stratification for Depression & Anxiety APCM Workflow
Optimize patient risk stratification for Depression & Anxiety using PHQ-9/GAD-7 scores and AI-driven monitoring to maximize APCM BHI add-on revenue.
Effective risk stratification is the foundation of Advanced Primary Care Management (APCM) for patients with Depression and Anxiety. By categorizing patients based on PHQ-9 and GAD-7 scores, medication complexity, and comorbidities, practices can deploy targeted AI-driven interventions that improve outcomes while capturing new BHI add-on revenue under codes G0568-G0570.
Manual risk stratification for behavioral health is often inconsistent, leading to missed BHI revenue opportunities and delayed intervention for high-risk patients who exhibit worsening PHQ-9 or GAD-7 scores between traditional office visits, resulting in poor longitudinal outcomes.
Step-by-Step Workflow
Baseline Screening & Data Capture
Use AI-powered calls to administer standardized PHQ-9 and GAD-7 screenings to the entire patient panel to establish a baseline for chronic care management and identify high-risk individuals.
- Automate calls for the week prior to scheduled appointments
- Ensure AI captures verbal score responses directly into the EHR
- Relying on paper forms that are not consistently digitized
- Failing to screen for both anxiety and depression simultaneously
Severity Categorization
Group patients into mild, moderate, or severe categories based on validated screening scores and historical data regarding treatment-resistant depression or prior hospitalizations.
- Set PHQ-9 thresholds of 10, 15, and 20 for tiering
- Cross-reference scores with previous six months of data
- Treating all patients with a diagnosis as having equal risk
- Ignoring stable patients who may be at risk of relapse
Comorbidity Mapping
Identify patients with co-occurring conditions like diabetes, heart disease, or chronic pain, as these individuals require higher-tier APCM monitoring and integrated care plans.
- Flag patients with more than three chronic conditions
- Prioritize those with conditions that worsen depression symptoms
- Viewing mental health in isolation from physical comorbidities
- Underestimating the impact of chronic pain on anxiety levels
Medication Complexity Review
Stratify risk based on antidepressant or anxiolytic regimens, focusing on those requiring frequent titration or monitoring for side effects and potential adverse reactions.
- Monitor patients on multiple psychotropic medications closely
- Use AI to check for medication adherence between visits
- Assuming high adherence without regular patient check-ins
- Failing to document side effect profiles for BHI billing
Social Determinants Assessment
Integrate SDOH data to identify barriers to psychotherapy or medication adherence that increase the risk of relapse or treatment non-compliance in mental health populations.
- Screen for transportation issues and financial barriers
- Assess social support systems for patients living alone
- Overlooking the role of isolation in depression severity
- Failing to update SDOH factors at least quarterly
Automated Monitoring Frequency
Set AI-driven follow-up cadences, such as weekly calls for high-risk patients and monthly for stable ones, to ensure continuous data flow for BHI documentation and patient safety.
- Align frequency with G0568-G0570 time requirements
- Adjust cadence immediately if screening scores fluctuate
- Using a one-size-fits-all follow-up schedule
- Manual tracking which leads to gaps in BHI billable time
Threshold-Based Escalation
Define specific score increases that trigger immediate clinical alerts for suicide risk assessment or medication review to prevent acute psychiatric episodes or ER visits.
- Set a 5-point PHQ-9 increase as a critical alert trigger
- Establish a clear protocol for AI-to-human handoff
- Delayed response to significant score changes
- Lack of a defined protocol for positive suicide ideation responses
Expected Outcomes
Increased capture of G0568-G0570 BHI add-on revenue
Reduction in emergency department visits for mental health crises
Improved longitudinal PHQ-9 and GAD-7 score stability
Higher patient engagement with psychotherapy referrals
Streamlined MIPS behavioral health quality reporting
Enhanced clinician efficiency through AI-led data collection
Frequently Asked Questions
These codes provide additional reimbursement on top of standard APCM payments for the intensive monitoring and care coordination required for behavioral health conditions like MDD and GAD.
Yes, modern AI-powered voice solutions can conduct standardized screenings with empathy, record scores directly into the EHR, and flag high-risk responses for immediate human intervention.
A significant change in screening scores, the addition of new comorbidities, or a failure to adhere to medication regimens typically triggers a risk tier reassessment and adjustment in care intensity.
Ready to transform your depression & anxiety practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo